Calming and Sleeping - Iran
In 2009, calming and sleeping products registered sales of IRR160bn, representing 16% current value growth over the previous year. However, in constant value terms sales declined 2% in the final year of the review period. The most popular product in this category is Alprazolam.
Euromonitor International's Calming and Sleeping Products in Iran report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2005-2009, allowing you to identify the sectors driving growth. Forecasts to 2014 illustrate how the market is set to change.
Product coverage:
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
* Get a detailed picture of the Consumer Health industry;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.
Euromonitor International has over 30 years experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town and Santiago and a network of over 600 analysts Globalwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.
Euromonitor International's Calming and Sleeping Products in Iran report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2005-2009, allowing you to identify the sectors driving growth. Forecasts to 2014 illustrate how the market is set to change.
Product coverage:
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
* Get a detailed picture of the Consumer Health industry;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.
Euromonitor International has over 30 years experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town and Santiago and a network of over 600 analysts Globalwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.
Calming and Sleeping in Iran
Euromonitor International
May 2010
LIST OF CONTENTS AND TABLES
Executive Summary
Consumer Health Experienced Dynamic Growth in 2009
Lack of Liquidity Is Threatening Domestic Suppliers
Domestic Suppliers Still Lead Sales
Distribution Mainly Allowed Through Chemists/pharmacies
Reduced Subsidies Will Have A Significant Impact on Unit Price and Consumption Behaviour
Market Indicators
Table 1 Consumer Expenditure on Health Goods and Medical Services 2004-2009
Table 2 Life Expectancy at Birth 2004-2009
Market Data
Table 3 Sales of Consumer Health by Sector: Value 2004-2009
Table 4 Sales of Consumer Health by Sector: % Value Growth 2004-2009
Table 5 Consumer Health Company Shares by Value 2005-2009
Table 6 Consumer Health Brand Shares by Value 2006-2009
Table 7 Sales of Consumer Health by Distribution Format: % Analysis 2004-2009
Table 8 Sales of Consumer Health by Sector and Distribution Format: % Analysis 2009
Table 9 Forecast Sales of Consumer Health by Sector: Value 2009-2014
Table 10 Forecast Sales of Consumer Health by Sector: % Value Growth 2009-2014
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication and Preventive Medicine
Generics
Switches
Definitions
Summary 1 Research Sources
Darou Pakhsh Pharmaceutical Mfg Co
Strategic Direction
Key Facts
Summary 2 Darou Pakhsh Pharmaceutical MFG Co: Key Facts
Summary 3 Darou Pakhsh Pharmaceutical MFG Co: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 4 Darou Pakhsh Pharmaceutical MFG Co: Competitive Position 2009
Dr Abidi Pharmaceutical Co
Strategic Direction
Key Facts
Summary 5 Dr Abidi Pharmaceutical Co: Key Facts
Summary 6 Dr. Abidi Pharmaceutical Co: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 7 Dr Abidi Pharmaceutical Co: Competitive Position 2009
Sina Darou Laboratories Co
Strategic Direction
Key Facts
Summary 8 Sina Darou Laboratories Co: Key Facts
Summary 9 Sina Darou Laboratories Co: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 10 Sina Darou Laboratories Co: Competitive Position 2009
Trends
Category Data
Table 11 Sales of Calming and Sleeping Products: Value 2004-2009
Table 12 Sales of Calming and Sleeping Products: % Value Growth 2004-2009
Table 13 Calming and Sleeping Products Company Shares by Value 2005-2009
Table 14 Calming and Sleeping Products Brand Shares by Value 2006-2009
Table 15 Forecast Sales of Calming and Sleeping Products: Value 2009-2014
Table 16 Forecast Sales of Calming and Sleeping Products: % Value Growth 2009-2014
Euromonitor International
May 2010
LIST OF CONTENTS AND TABLES
Executive Summary
Consumer Health Experienced Dynamic Growth in 2009
Lack of Liquidity Is Threatening Domestic Suppliers
Domestic Suppliers Still Lead Sales
Distribution Mainly Allowed Through Chemists/pharmacies
Reduced Subsidies Will Have A Significant Impact on Unit Price and Consumption Behaviour
Market Indicators
Table 1 Consumer Expenditure on Health Goods and Medical Services 2004-2009
Table 2 Life Expectancy at Birth 2004-2009
Market Data
Table 3 Sales of Consumer Health by Sector: Value 2004-2009
Table 4 Sales of Consumer Health by Sector: % Value Growth 2004-2009
Table 5 Consumer Health Company Shares by Value 2005-2009
Table 6 Consumer Health Brand Shares by Value 2006-2009
Table 7 Sales of Consumer Health by Distribution Format: % Analysis 2004-2009
Table 8 Sales of Consumer Health by Sector and Distribution Format: % Analysis 2009
Table 9 Forecast Sales of Consumer Health by Sector: Value 2009-2014
Table 10 Forecast Sales of Consumer Health by Sector: % Value Growth 2009-2014
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication and Preventive Medicine
Generics
Switches
Definitions
Summary 1 Research Sources
Darou Pakhsh Pharmaceutical Mfg Co
Strategic Direction
Key Facts
Summary 2 Darou Pakhsh Pharmaceutical MFG Co: Key Facts
Summary 3 Darou Pakhsh Pharmaceutical MFG Co: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 4 Darou Pakhsh Pharmaceutical MFG Co: Competitive Position 2009
Dr Abidi Pharmaceutical Co
Strategic Direction
Key Facts
Summary 5 Dr Abidi Pharmaceutical Co: Key Facts
Summary 6 Dr. Abidi Pharmaceutical Co: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 7 Dr Abidi Pharmaceutical Co: Competitive Position 2009
Sina Darou Laboratories Co
Strategic Direction
Key Facts
Summary 8 Sina Darou Laboratories Co: Key Facts
Summary 9 Sina Darou Laboratories Co: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 10 Sina Darou Laboratories Co: Competitive Position 2009
Trends
Category Data
Table 11 Sales of Calming and Sleeping Products: Value 2004-2009
Table 12 Sales of Calming and Sleeping Products: % Value Growth 2004-2009
Table 13 Calming and Sleeping Products Company Shares by Value 2005-2009
Table 14 Calming and Sleeping Products Brand Shares by Value 2006-2009
Table 15 Forecast Sales of Calming and Sleeping Products: Value 2009-2014
Table 16 Forecast Sales of Calming and Sleeping Products: % Value Growth 2009-2014
